Preventing cardiac implantable electronic device infections.

Area of Science:

• Cardiology
• Infectious Diseases
• Biomedical Engineering

Background:

• Cardiac implantable electronic devices (CIEDs) improve heart disease outcomes, but device-related infections (DRIs) are increasing.
• Higher rates of DRI are linked to more complex procedures and sicker patients with comorbidities.
• Current understanding of DRI pathophysiology aids antibiotic use, but evidence for optimal prophylaxis is limited.

Purpose of the Study:

• To review the epidemiology, pathophysiology, and clinical presentation of CIED-related infections.
• To identify risk factors associated with device-related infections.
• To examine current and emerging evidence for strategies to prevent device-related infections.

Main Methods:

• Literature review of studies on cardiac implantable electronic device infections.
• Analysis of epidemiological data and risk factors for device-related infections.
• Evaluation of evidence for antibiotic prophylaxis and other preventive strategies.

Main Results:

• Device-related infection rates are rising disproportionately to CIED implantation rates, exceeding 2% in many cases.
• Increased patient comorbidities and procedural complexity contribute to higher DRI rates.
• Optimal prophylactic antibiotic regimens require further evidence-based research.

Conclusions:

• Identifying high-risk patients is crucial for procedural planning and targeted interventions.
• Further research is needed to establish optimal antibiotic prophylaxis guidelines for preventing CIED infections.
• Continued learning is essential for effectively managing and preventing device-related infections in CIED patients.